# Selenium Immune Function Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/selenium-immune-function-randomized-trial-evidence-review
Category: evidence-review
Summary: Selenium Immune Function Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass a
Last reviewed: 2026-07-05
Reviewed by: Migaku Evidence Review
# Selenium Immune Function Randomized Trial: What the Evidence Says

## Quick Answer

Selenium Immune Function Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Efficacy of Selenium Supplementation in Graves’ Orbitopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis | systematic review | 1 | 2026-06-17 | 10.3390/jcm15124710 |
| Photobiomodulation Therapy in Chronic Autoimmune Thyroiditis: A Systematic Review of Molecular Mechanisms and Clinical Applications | systematic review | 1 | 2026-03-26 | 10.3390/ijms27073007 |

## What The Sources Report

- Subsequent studies expanded the evidence base but introduced uncertainty: a Mexican randomized study suggested improved clinical activity and reduced progression in mild GO, whereas trials in Sel-sufficient settings and in inactive moderate-to-severe GO have reported more heterogeneous effects. [Kostadinov Nikolay (2026); evidence level 1]
- As a result, many patients will experience ongoing autoimmunity, abnormal thyroid morphology, or residual symptoms after their hormone replacement is optimized. [Berisha-Muharremi Venera (2026); evidence level 1]
- In the thyroid gland, the increased perfusion may improve the viability of thyroid follicular cells, the synthesis of hormones, and tissue regeneration. [Berisha-Muharremi Venera (2026); evidence level 1]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For selenium immune function randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Kostadinov Nikolay (2026). Efficacy of Selenium Supplementation in Graves’ Orbitopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis. DOI: 10.3390/jcm15124710. PMCID: PMC13302020. PMID: 42355878. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13302020/
- Berisha-Muharremi Venera (2026). Photobiomodulation Therapy in Chronic Autoimmune Thyroiditis: A Systematic Review of Molecular Mechanisms and Clinical Applications. DOI: 10.3390/ijms27073007. PMCID: PMC13073973. PMID: 41977196. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13073973/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.